We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lab21 Secures New Patents in Hepatitis C Drug Resistance and Fluorescent Carbon-based Nanoparticle Technology

News   Dec 08, 2010

 
Lab21 Secures New Patents in Hepatitis C Drug Resistance and Fluorescent Carbon-based Nanoparticle Technology
 
 
Advertisement
 

RELATED ARTICLES

Human Cell “Membrane-on-Chip'” Helps Hunt for Drugs Against COVID-19

News

Researchers have created a human cell '"membrane on a chip" that allows continuous monitoring of how drugs and infectious agents interact with our cells. The device could soon be used to screen potential drug candidates against SARS-CoV-2.

READ MORE

Understanding How Magnet Nanoparticles Affect Cancer Cells in the Liver

News

Researchers have studied how magnet nanoparticles affect cancer cells in the human liver.

READ MORE

Tiny Protein Has a Big Impact on Health and Longevity

News

A new study led by researchers at the USC Leonard Davis School of Gerontology is the first to demonstrate that a tiny protein has a big impact on health and longevity in both animals and humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE